Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FJRN4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,652
Award facts
- Contract value 100% obligated
- $14,651.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,651.90 for Dupixent 300 mg/2 mL pen injectors on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a monoclonal antibody treatment used for multiple indications including moderate-to-severe eczema, asthma, and chronic rhinosinusitis with nasal polyps, representing a specialty pharmaceutical product commonly procured for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical support mechanism. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceuticals, medical supplies, vaccines, and specialty medications to support Defense Health Agency operations and other federal healthcare customers worldwide. As a major pharmaceutical distributor with extensive federal contracting experience, AmerisourceBergen regularly fulfills critical medical procurement needs through the DLA Medical Supply Chain across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJRN4?
SPE2DB25FJRN4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FJRN4 worth?
The government has obligated $14,652 on SPE2DB25FJRN4.
Is contract SPE2DB25FJRN4 an order under another contract?
Yes. SPE2DB25FJRN4 is a delivery order under SPE2DB22D2005, an indefinite delivery contract.
Was contract SPE2DB25FJRN4 competed?
The extent of competition for SPE2DB25FJRN4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award